Lorvotuzumab mertansine - CAS 1008106-64-6

Lorvotuzumab mertansine - CAS 1008106-64-6 Catalog number: BADC-02002

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Lorvotuzumab mertansine is an ADC consists of a CD56-targeting antibody conjugated with an antimitotic agent. Lorvotuzumab mertansine is designed for the treatment of CD56-expressing cancers.

Category
Antibody-Drug Conjugates (ADCs)
Product Name
Lorvotuzumab mertansine
CAS
1008106-64-6
Catalog Number
BADC-02002
Purity
95%

Ordering Information

Catalog Number Size Price Quantity
BADC-02002 -- $-- Inquiry
Description
Lorvotuzumab mertansine is an ADC consists of a CD56-targeting antibody conjugated with an antimitotic agent. Lorvotuzumab mertansine is designed for the treatment of CD56-expressing cancers.
Synonyms
IMGN901; IMGN-901; IMGN 901
The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Historical Records: Lorvotuzumab mertansine
Why Choose BOC Sciences?

Customer Support

Providing excellent 24/7 customer service and support

Project Management

Offering 100% high-quality services at all stages

Quality Assurance

Ensuring the quality and reliability of products or services

Global Delivery

Ensuring timely delivery of products worldwide

Questions & Comments
Verification code
Send Inquiry
Verification code
Resources & Supports
)
0
Inquiry Basket

No data available, please add!

Delete selectedGo to checkout

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

x